Branch

Clive Leslie Branch, Harlow GB

Patent application number	Description	Published
20080318944	N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - Disclosed are N-aroyl cyclic amine derivatives having the formula:	12-25-2008
20090012073	N-AROYL CYCLIC AMINES - Disclosed are N-aroyl cyclic amine derivatives having the formula:	01-08-2009
20090012083	N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - Disclosed are N-aroyl cyclic amine derivatives having the formula:	01-08-2009
20090012122	N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - Disclosed are N-aroyl cyclic amine derivatives having the formula:	01-08-2009
20090029986	N-AROYL CYCLIC AMINES - Disclosed are N-aroyl cyclic amine derivatives having the formula:	01-29-2009
20090036442	N-AROYL CYCLIC AMINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS - Disclosed are N-aroyl cyclic amine derivatives having the formula:	02-05-2009
20090093478	N-AROYL CYCLIC AMINES - Disclosed are N-aroyl cyclic amine derivatives having the formula:	04-09-2009

Patent applications by Clive Leslie Branch, Harlow GB

Patent application number	Description	Published
20100047249	INHIBITION OF FcyR-MEDIATED PHAGOCYTOSIS WITH REDUCED IMMUNOGLOBULIN PREPARATIONS - The invention relates to pharmaceutical compositions for inhibiting FcγR-mediated phagocytosis comprising a reduced immunoglobulin inhibitor of FcγR-mediated phagocytosis, such as anti-D, in combination with a pharmaceutically acceptable carrier. The invention also relates to methods for treating or preventing an autoimmune or alloimmune disease comprising administering to a subject in need thereof a therapeutically effective amount of a reduced immunoglobulin inhibitor of FcγR-mediated phagocytosis.	02-25-2010